This expansion comes after a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024, in the U.S., largely driven by the systems success, and clinical data on that formula reinforcing its effectiveness in supporting GLP-1 production
Until then, the most reliable approach is to partner with your healthcare provider on evidence-based strategies that support safe, sustainable, and lasting results
* **Step Therapy:** Some plans may require you to try and fail older, less expensive weight loss medications (like phentermine, orlistat) before they will approve Zepbound or Wegovy
European Journal of Nutrition, 59 (3), 11631170
"Complete Peptide Reconstitution and Storage Guide: Best Practices for Maintaining Stability." Pharmaceutical Peptides Quarterly, January 2025